Predicting Treatment Response to Gabapentin in Women with Chronic Pelvic Pain
Author Information
Author(s): Coxon Lydia, Amer Maryam, Daniels Jane, Doust Ann M., Mackenzie Scott C., Horne Andrew W., Vincent Katy
Primary Institution: Nuffield Department of Women’s and Reproductive Health, University of Oxford
Hypothesis
Can baseline measures predict treatment response to gabapentin in women with unexplained chronic pelvic pain?
Conclusion
The study identified that lower worst pain intensity, lower bladder symptom scores, and higher mental health scores are associated with better treatment responses to gabapentin.
Supporting Evidence
- Lower worst pain intensity was associated with a higher likelihood of treatment response.
- Lower bladder symptom scores predicted better outcomes with gabapentin.
- Higher mental component quality of life scores were linked to improved treatment responses.
Takeaway
This study helps doctors understand which women might benefit from gabapentin for pelvic pain, showing that those with less severe symptoms may do better.
Methodology
The study analyzed data from a randomized-controlled trial, using binary logistic regression to identify predictors of treatment response and side effects.
Potential Biases
Potential biases include the reliance on self-reported measures and the exclusion of certain demographic factors.
Limitations
The analysis is exploratory and not designed to definitively identify predictors; it may not apply to all chronic pelvic pain cases.
Participant Demographics
Women aged 18-50 with chronic pelvic pain and no obvious pelvic pathology.
Statistical Information
P-Value
0.029
Confidence Interval
[0.217, 0.712]
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website